Decaens T - Search Results

1

Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals.

Macek Jílková Z, Seigneurin A, Coppard C, Ouaguia L, Aspord C, Marche PN, Leroy V, Decaens T. Macek Jílková Z, et al. Among authors: decaens t. Cancers (Basel). 2020 Dec 18;12(12):3820. doi: 10.3390/cancers12123820. Cancers (Basel). 2020. PMID: 33352852 Free PMC article.

2

Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.

Gregory J, Tselikas L, Allimant C, de Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M. Gregory J, et al. Among authors: decaens t. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):921-928. doi: 10.1007/s00259-022-06002-5. Epub 2022 Oct 25. Eur J Nucl Med Mol Imaging. 2023. PMID: 36282299 Review.

3

Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.

Ramzan M, Sturm N, Decaens T, Bioulac-Sage P, Bancel B, Merle P, Tran Van Nhieu J, Slama R, Letoublon C, Zarski JP, Jouvin-Marche E, Marche PN, Leroy V. Ramzan M, et al. Among authors: decaens t. Liver Int. 2016 Mar;36(3):434-44. doi: 10.1111/liv.12927. Epub 2015 Sep 29. Liver Int. 2016. PMID: 26215124

4

Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17(+) neutrophils.

Macek Jilkova Z, Afzal S, Marche H, Decaens T, Sturm N, Jouvin-Marche E, Huard B, Marche PN. Macek Jilkova Z, et al. Among authors: decaens t. Liver Int. 2016 Aug;36(8):1116-24. doi: 10.1111/liv.13060. Epub 2016 Feb 3. Liver Int. 2016. PMID: 26749555

5

Performance of bile aspiration plus brushing to diagnose malignant biliary strictures during endoscopic retrograde cholangiopancreatography.

Roth GS, Bichard P, Fior-Gozlan M, Roth H, Auroux J, Risse O, Letoublon C, Laverrière MH, Bricault I, Leroy V, Decaens T. Roth GS, et al. Among authors: decaens t. Endosc Int Open. 2016 Sep;4(9):E997-E1003. doi: 10.1055/s-0042-108854. Epub 2016 Aug 9. Endosc Int Open. 2016. PMID: 27652308 Free PMC article.

6

Sex Differences in Spontaneous Degranulation Activity of Intrahepatic Natural Killer Cells during Chronic Hepatitis B: Association with Estradiol Levels.

Macek Jilkova Z, Decaens T, Marlu A, Marche H, Jouvin-Marche E, Marche PN. Macek Jilkova Z, et al. Among authors: decaens t. Mediators Inflamm. 2017;2017:3214917. doi: 10.1155/2017/3214917. Epub 2017 Apr 2. Mediators Inflamm. 2017. PMID: 28469292 Free PMC article.

7

Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma.

Roth GS, Macek Jilkova Z, Zeybek Kuyucu A, Kurma K, Ahmad Pour ST, Abbadessa G, Yu Y, Busser B, Marche PN, Leroy V, Decaens T. Roth GS, et al. Among authors: decaens t. Mol Cancer Ther. 2017 Oct;16(10):2157-2165. doi: 10.1158/1535-7163.MCT-16-0602-T. Epub 2017 May 31. Mol Cancer Ther. 2017. PMID: 28566435

8

Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.

Jilkova ZM, Kuyucu AZ, Kurma K, Ahmad Pour ST, Roth GS, Abbadessa G, Yu Y, Schwartz B, Sturm N, Marche PN, Hainaut P, Decaens T. Jilkova ZM, et al. Among authors: decaens t. Oncotarget. 2018 Jan 23;9(13):11145-11158. doi: 10.18632/oncotarget.24298. eCollection 2018 Feb 16. Oncotarget. 2018. PMID: 29541403 Free PMC article.

9

De Novo Malignancies Screening After Liver Transplantation for Alcoholic Liver Disease: A Comparative Opportunistic Study.

Renaud L, Hilleret MN, Thimonier E, Guillaud O, Arbib F, Ferretti G, Jankowski A, Chambon-Augoyard C, Erard-Poinsot D, Decaens T, Boillot O, Leroy V, Dumortier J. Renaud L, et al. Among authors: decaens t. Liver Transpl. 2018 Dec;24(12):1690-1698. doi: 10.1002/lt.25336. Liver Transpl. 2018. PMID: 30207421

10

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.

Ouaguia L, Leroy V, Dufeu-Duchesne T, Durantel D, Decaens T, Hubert M, Valladeau-Guilemond J, Bendriss-Vermare N, Chaperot L, Aspord C. Ouaguia L, et al. Among authors: decaens t. Front Immunol. 2019 Feb 4;10:112. doi: 10.3389/fimmu.2019.00112. eCollection 2019. Front Immunol. 2019. PMID: 30778353 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page